Volunteers towards Madrid.
Castellón, 2011-September A group of volunteers from the Consortium hospital Provincial de Castellón departed yesterday for the Madrid town of Pozuelo de Alarcón to participate this weekend at a meeting with fellow Spain and Portugal in order to exchange experiences and receive training.
The IDIAP receives the ISO 9001 quality certification, advice and support to research projects
el Instituto Universitario de Investigación in primary care, IDIAP Jordi Gol, dedicated to the promotion of research in the first level of care Achieves ISO 9001 certification for its activities of advice and support to research projects
Spain, September 2011.- AENOR, Asociación Española de normalización y certificación, has certiticat the Institute for research in primary care, IDIAP Jordi Gol, has a quality management system in accordance with the norm UNE – EN ISO 9001: 2008 for its activities of advice and support in the management of research projects in attention primary and community health.
This certification is according to the Dra. conception Violan, Manager of the IDIAP “a very important recognition of the work done since the IDIAP.” We always strive to provide primary care researchers a maximum quality framework for the development and management of their projects. In the IDIAP us concerned always ensure quality in our work of advice and support, so that projects are developed in the more competitive, efficient and effective way both in Catalan, such as national and European level “.
“what is the IDIAP?
The Foundation Jordi Gol i Gurina was created in 1996 by the Catalan Health Institute, with the aim of promoting and managing innovation, training, teaching and research clinical, epidemiological and health services in the field of primary health care.
In 2006, he became the Institute for research in primary care Jordi Gol (IDIAP Jordi Gol), through the signing of an economic agreement with the Department of health and the Autonomous University of Barcelona.
From 2010 it is attached to the UAB as a University Institute of research in primary care.
Since the IDIAP is working to make available to researchers the means and services that enable them to improve the development of their research; credits also ensures projects and the process of research., promotes cooperation with other national and international research bodies and participates in initiatives public or private establishment of innovative platforms for management or research in the field of the
attention primary.
Day world of Alzheimer – documentary “instante”.
Spain, 2011-September the Alzheimer’s disease is a degenerative disease of the brain cells – neurons – and progressive nature of still unknown origin. It is the cause of invalidity, dependency and mortality more common in older people. It is also the most common trigger for mental disorder in the Western world, constituting between 60 and 75 per cent of all dementias. Its incidence and prevalence increases almost exponentially with aging.
Nearly 700,000 people are affected in Spain and manifested more than 100,000 new patients to the year taking into account the ageing of the population and the future increase in people older than 80 years, he is expected that the number of sufferers is to double by 2020 and triple by 2050.
Grünenthal Pharma, leading company in the treatment of pain and with extensive knowledge in the area of the Central nervous system, supports the fight against Alzheimer’s disease and is sponsoring the documentary, “ moments. Family around Alzheimer’s ”, which will be issued this Wednesday, September 21, international day of the Alzheimer’s in the 2 television programme “ La Aventura del Saber ”, at 10: 00.
The filmmaker Ander Duque collects in this piece the harsh reality of several sufferers of Alzheimer’s disease, as well as the daily tragedies and small triumphs of patients and their families.
If you want to see the trailer for the documentary click here
Read MoreSpain continues without a strategic plan against Alzheimer’s.
21 September: day world of Alzheimer’s.
-In Spain there are about 600,000 patients although it is estimated that there are about 200,000 cases more undiagnosed
-A precocious, basic diagnostics to improve the quality of life of patients
-Spain must overcome the limitations of the institutional and structures health care if you want to move forward in their investigation
Spain, 2011-September today 21 September is the day world of Alzheimer’s disease, the most common disease of dementia. According to the data managed by the Sociedad Española de NeurologÃa (SEN), there are more than 600,000 patients in Spain and it is estimated that approximately 200,000 others were undiagnosed.
But in addition, the progressive ageing of the population will in the coming decades grow very significantly the number of people older than 65 years, and it is estimated that in about 30-40 years be can double the current figure, which will involve more than one and a half million people affected by the disease in Spain.
“ Although in recent years important progress has been made in the knowledge of the disease, as well as in its early diagnosis, it is necessary to continue efforts to promote health education of the population about what are the first symptoms and promoting effective coordination between primary and specialized care to ensure the best response to the demand for diagnostic the person who complains of memory failures. Diagnostic and therapeutic clinical research remains crucial before one of the diseases that most will increase in incidence in the next few years ”, says Dr. Pablo Martinez-Lage Ãlvarez, Coordinator of the Group’s behavior and dementias of the society Spanish of Neurology. “ in particular, in Spain, clinical research is presenting a significant delay for years compared to other developed countries. It is necessary to enhance clinical dementia units, the banks of brains, studies clinicopatologicos, projects of anatomical and functional neuroimaging and clinical centers that support research ”. Association Alzheimer’s disease International (ADI) has just published its annual report which calls for each country a strategic anti-Alzheimer’s to optimize the diagnosis and treatment, improve access and the management of resources and promote research. To date, in Europe only France, Great Britain and Germany have a plan as well.
Some 25 million people suffer from Alzheimer’s disease in the world. There are several risk factors: demographic, old age, female sex, illiteracy and medical history, primarily those known as cardiovascular risk – diabetes, smoking, high blood pressure, increase in cholesterol, factors and others such as depression, menopause, etc.
Alzheimker disease is treatment. There are four drugs that have demonstrated effectiveness in enhancing their cognitive behavioural symptoms and functional. They are drugs that can be “ stabilize ” between one to two years the evolution of the symptoms and they can even delay the need for admission in residence. “ Therefore, a diagnosis early becomes an essential tool for improving the quality of life of patients. The problem is that often the initial Stadium may go unnoticed. As the disease has a form of varied appearance, does not follow a unique pattern, and has a gradual development sometimes it is difficult for the patient or their families distinguish early symptoms of Alzheimer’s own age changes ”, explains Dr. Pablo Martinez-Lage Ãlvarez.
Alzheimer’s disease is a degenerative process most likely produced by deposition of protein beta-amyloid and causing a gradual loss of neurons and their connections. Except in the rare cases in which the disease is due to a mutation genetic the Alzheimer has no known cause. For distribution at the cerebral level produces cognitive symptoms, behavioral symptoms and ultimately loss of functional capacity and limited autonomy and independence. Initial symptoms include:
-progressive loss of memory
-lack of
-difficulty to perform usual tasks
-problems with the language
-disorientation in time and space
-difficulty to recognize objects and people
-decrease of the trial, with problems to distinguish right from wrong
-changes in mood or behavior
-lost in familiar places
-Show difficulty making decisions
-lack initiative and motivation
-show signs of depression and aggressive
-losing interest in hobbies or interests prior
-difficulty handling money
” is important to know that age, if same, does not produce dementia. The age can be done to decrease the agility to learn or to remember but age does not explain the loss of memory, does not justify the daily, repeated and persistent memory bug. When someone wondering if some loved, if he or she is starting with the Alzheimer’s time to go to the doctor and that is the moment in which the doctor must be prepared to give a professional answer based on a clinical evaluation and a proportionate and appropriate diagnostic study and total respect to rights and the autonomy of the individual consultation.
Read MoreThe majority of children with grandparents with alzheimer declare afraid that the grandfather does not recognise them.
21 September day world against Alzheimer’s.
-a study by the Institute for research in primary care, IDIAP Jordi Gol, analyzes how affects children of Alzheimer’s disease suffered by his grandparents
-in Spain, about 600,000 people suffering from dementia, and these 400,000 have Alzheimer’s disease
-children indicate that it has changed the relationship with the grandfather with the disease, but they do not live in a negative way and almost 100% ensures that the grandfather / to gets happy when you see them
-50% of children say that it gives them shame that friends know the disease of the grandfather
– among the children studied, in any case, there is a negative impact of the disease from grandfather / on their school performance
Spain, 2011-September the study “how live grandchildren grandparents Alzheimer’s disease?.” Qualitative study in primary care “it aims to know as the grandfather of disease has affected grandson, what concerns are children to the disease, if they have observed changes in the dedication of parents towards them since the grandfather has the disease and to identify if the parents have observed changes in behavior in children.” More than 30 grandchildren have interviewed over a period of 6 months.
Currently, the elderly represent an essential social resource in a society where, typically, two members of the family must work. According to the Imserso report of year 2008 on “Older persons in Spain”, more than 72% of Spanish grandparents caring for or have taken care of their grandchildren, especially when these are school-age. That is why, as pointed out by Maria Jesus Megiddo, primary e nurse principal investigator of the project “that we wanted to focus on children from 6 to 13 years in Catalonia that have a normal relationship with a sick with Alzheimer’s grandfather”.
Results of the study
– on the understanding of the disease, 100 per cent of children said that have explained you the disease and that they understand what it is. In all cases, parents were those who explained to children the disease. But some parents did not want their children to participate in the study because they will not talk to the grandfather / to have the disease.
-50% of children say that it gives them shame that friends know the disease of the grandfather.
-86,37 per cent of children say they have noticed changes in the dedication of their parents toward them, following the illness of the grandfather, but almost all a 73.73% also say that this less dedication of parents has not affected them and that understand given the disease of the grandfather.
-A 72.73% of the children of the disease of Alzheimer’s talk with their parents, but few speak it outside the family. Only a 13: 53% speak it with friends.
-100% of the children declare usually help to the grandfather in basic activities of daily living (eating, walking, getting up), in activities that are difficult for grandparents (change the channel of TV, stimulation of memory work) and leisure activities and distractions (talk)(keep them company, tell them stories, etc…).
-all children say they notice changes in the relationship with the grandfather and a 99,78% declared that they perceive as the grandfather / to gets happy when ve.
-18,18% of children have been difficulties when it comes to sleep, and has agreed that they are children who live under the same roof as the grandfather sick.
-A 62.5% of the nochildren show fear that Grandpa/a does not know, but only 37.5% show concern and fear for the disease
– Finally, the majority of children say that you see nothing positive in disease of the grandfather. But in their explanations will foreshadow certain aspects which might (learn how to take care, have patience with him, estimation despite the shortcomings…).
what is the IDIAP?
The Foundation Jordi Gol i Gurina was created in 1996 by the Catalan Health Institute, with the aim of promoting and managing innovation, training, teaching and research clinical, epidemiological and health services in the field of primary health care.
In 2006, he became the Institute for research in primary care Jordi Gol (IDIAP Jordi Gol), through the signing of an economic agreement with the Department of health and the Autonomous University of Barcelona.
From 2010 it is attached to the UAB as a University Institute of research in primary care.
The IDIAP works to make available to researchers the means and services that enable them to improve the development of their research; accredits and guarantees the projects and the process of research.
In addition, it promotes cooperation with other national and international research organizations and participates in initiatives public or private establishment of innovative platforms for management or research in the field of primary care.
From August 2011 has the quality certification ISO 9001: 2008 for its activities of support and advice to research projects
Read More